Suchergebnis | Hamburg Open Science

Facetten

20 Einträge gefunden

Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
2020 - Forschungsinformationssystem des UKE
Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
2020 - Forschungsinformationssystem des UKE
Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer
2018 - Forschungsinformationssystem des UKE
Role of HYAL1 expression in primary breast cancer in the formation of brain metastases
2017 - Forschungsinformationssystem des UKE
Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients
2015 - Forschungsinformationssystem des UKE
Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
2014 - Forschungsinformationssystem des UKE - frei zugänglich
Prognostic relevance of glycosylation-associated genes in breast cancer
2014 - Forschungsinformationssystem des UKE
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor
2014 - Forschungsinformationssystem des UKE - frei zugänglich
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer
2013 - Forschungsinformationssystem des UKE
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers
2013 - Forschungsinformationssystem des UKE
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
2013 - Forschungsinformationssystem des UKE
Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
2012 - Forschungsinformationssystem des UKE
Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
2012 - Forschungsinformationssystem des UKE - frei zugänglich
Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.
2011 - Forschungsinformationssystem des UKE
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin
2011 - Forschungsinformationssystem des UKE
Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.
2011 - Forschungsinformationssystem des UKE
Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.
2010 - Forschungsinformationssystem des UKE
Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
2010 - Forschungsinformationssystem des UKE - frei zugänglich
Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
2010 - Forschungsinformationssystem des UKE
Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
2008 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer

Role of HYAL1 expression in primary breast cancer in the formation of brain metastases

Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

Prognostic relevance of glycosylation-associated genes in breast cancer

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor

Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer

Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.

Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.

Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.

Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin

Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.